Concepedia

Stephanie Curry

SC

Statistics

Publications

24

Citations

822

H-Index

17

Active since

2003

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

WuXi AppTec (China)

United States Military Academy

Southern Research Institute

Institute of Virology of the Slovak Academy of Sciences

Stephanie Curry is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

2003–2018

24

Publications

24

Regulation of Eotaxin Gene Expression by TNF-α and IL-4 Through mRNA Stabilization: Involvement of the RNA-Binding Protein HuR

Ulus Atasoy, Stephanie Curry, Isabel López de Silanes et al. · The Journal of Immunology · 2003 · 119 citations · Full text

, , +25

Susceptibilities of Genotype 1a, 1b, and 3 Hepatitis C Virus Variants to the NS5A Inhibitor Elbasvir

Rong Liu, Stephanie Curry, Patricia McMonagle et al. · Antimicrobial Agents and Chemotherapy · 2015 · 76 citations · Full text

The Combination of Grazoprevir, a Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor, and Elbasvir, an HCV NS5A Inhibitor, Demonstrates a High Genetic Barrier to Resistance in HCV Genotype 1a Replicons

Frederick Lahser, Karin Bystol, Stephanie Curry et al. · Antimicrobial Agents and Chemotherapy · 2016 · 57 citations · Full text

, , +17

Antiviral activity of boceprevir monotherapy in treatment-naive subjects with chronic hepatitis C genotype 2/3

Marcelo Silva, Michelle Treitel, Donald J. Graham et al. · Journal of Hepatology · 2013 · 56 citations · Full text

Functional Analysis of the Chemokine Receptor CCR3 on Airway Epithelial Cells

Lisa A. Beck, B. Tancowny, Mary Brummet et al. · The Journal of Immunology · 2006 · 53 citations · Full text

1–5 of 24